EP at Alaska Heart Institute
Cardiology
Dr. Steven J. Compton, MD
|
|
Give Review
Steven J. Compton, MD practices Cardiology. He attended University of Washington School of Medicine. He received 3 awards: "Regional Top Doctor", "Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Steven Compton is a published MD. He has 44 publications published. The most current publication "RANTES, macrophage-inhibitory protein 1alpha, and the eosinophil product major basic protein are released into upper respiratory secretions during virus-induced asthma..." Steven Compton accepts Medicare payments and is listed with Medicare.gov.
Publications
- Arrhythmia discrimination using hemoglobin spectroscopy in humans.
- Inflammatory stimuli up-regulate transient receptor potential vanilloid-1 expression in human bronchial fibroblasts.
- Palmitoylation of Human Proteinase-Activated Receptor-2 Differentially Regulates Receptor Triggered ERK1/2 Activation, Calcium Signalling, and Endocytosis.
- N-linked glycosylation regulates human proteinase-activated receptor-1 cell surface expression and disarming via neutrophil proteinases and thermolysin.
- Transient receptor potential vanilloid-1-mediated calcium responses are inhibited by the alkylamine antihistamines dexbrompheniramine and chlorpheniramine.
- Clinical and electrical performance of expanded polytetrafluoroethylene-covered defibrillator leads in comparison to traditional leads.
- Proteinase-activated receptor-2 activating peptides: distinct canine Coronary artery receptor systems.
- Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.
- Multi-center clinical experience with a lumenless, catheter-delivered, bipolar, permanent pacemaker lead: implant safety and electrical performance.
- Proteinase-activated receptor2 agonists upregulate granulocyte colony-stimulating factor, IL-8, and VCAM-1 expression in human bronchial fibroblasts.
- Reduction of RV pacing by continuous optimization of the AV interval.
- Continuous template collection and updating for electrogram morphology discrimination in implantable cardioverter defibrillators.
- Automatic measurement of Atrial pacing thresholds in dual-chamber pacemakers: clinical experience with Atrial capture management.
- Expression and characterization of the intracellular vanilloid receptor (TRPV1) in bronchi from patients with Chronic cough.
- Results of catheter ablation of typical Atrial flutter.
- Remote monitoring of implantable cardioverter defibrillators: a prospective analysis.
- A new oral therapy for long QT Syndrome: long-term oral potassium improves repolarization in patients with HERG mutations.
- International Union of Pharmacology. XXVIII. Proteinase-activated receptors.
- Problems in monitoring needs for care of long term psychiatric patients: evaluating a service for casual attenders.
- Mass, charge, and subcellular localization of a unique secretory product identified by the basophil-specific antibody BB1.
- RANTES, macrophage-inhibitory protein 1alpha, and the eosinophil product major basic protein are released into upper respiratory secretions during virus-induced asthma...
- Sesquiflutter.
- Human mast cell tryptase stimulates the release of an IL-8-dependent neutrophil chemotactic activity from human umbilical vein endothelial cells (HUVEC).
- The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA fo...
- Interaction of human mast cell tryptase with endothelial cells to stimulate inflammatory cell recruitment.
- Mast cell tryptase as a mediator of hyperresponsiveness in human isolated bronchi.
- Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells.
- Intra-atrial conduction block along the mitral Valve annulus during accessory pathway ablation: evidence for a left atrial "isthmus".
- Intrathoracic impedance vs daily weight monitoring for predicting worsening Heart failure events: results of the Fluid Accumulation Status Trial (FAST).
- Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2.
- Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT Syndrome: ECG findings identify genotypes.
- Successful pediatric stenting of a nonthrombotic Coronary occlusion as a complication of radiofrequency catheter ablation.
- A polymorphic protease-activated receptor 2 (PAR2) displaying reduced sensitivity to trypsin and differential responses to PAR agonists.
- Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants.
- Genetically defined therapy of inherited long-QT Syndrome. Correction of abnormal repolarization by potassium.
- Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway.
- Glycosylation and the activation of proteinase-activated receptor 2 (PAR(2)) by human mast cell tryptase.
- Colitis induced by proteinase-activated receptor-2 agonists is mediated by a neurogenic mechanism.
- Restricted ability of human mast cell tryptase to activate proteinase-activated receptor-2 in rat aorta.
- Glycosylation of human proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signalling.
- Optical calcium sensors: development of a generic method for their introduction to the cell using conjugated cell penetrating peptides.
- Characterization of a novel protein from Proatheris superciliaris venom: proatherocytin, a 34-kDa platelet receptor PAR1 agonist.
- Expression of proteinase-activated receptor 2 on human primary gastrointestinal myofibroblasts and stimulation of prostaglandin synthesis.
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
- Clinical Cardiac Electrophysiology
Accepted Insurances
- Aetna
- Assurant Health
- Blue Card PPO
- Commercial Insurance Company
- Coventry Health Care
- First Choice Health
- HealthSmart
- Humana
- Medicare MCR
- Heritage Signature
- Providence Health Plans
- United Healthcare
- WellCare
- Wells Fargo Insurance
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
University of Washington School of Medicine -
University of Utah -
University of Washington
Drug Facts
| NPI NUMBER | 1548285901 | |
| NPPES Provider LastName | COMPTON | |
| NPPES Provider FirstName | STEVEN | |
| NPPES Provider ZIPCode | 99508 | |
| NPPES Provider State | AK | |
| Specialty Description | Cardiac Electrophysiology | |
| Total Claim Count | 372.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 3.23 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1548285901 |
| Last Name Of The Provider | COMPTON |
| First Name Of The Provider | STEVEN |
| View All |
Similar Doctors
|
|
Dr. David W. Sonneborn, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark A. Selland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter M. Sapin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mario Binder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda A. Ireland, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher A. Michaeles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Krzysztof W. Balaban, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa N. Gray, DO
This Doctor is OpenDoctor Recommended.
|